Biomarkers and Liquid Biopsy for Early Detection of Colorectal Cancer

AACR is the proud Scientific Partner for Stand Up To Cancer (SU2C), and for Colorectal Cancer Awareness Month, we asked the co-leader of the SU2C–Dutch Cancer Society Dream Team on Molecular Early Detection of Colorectal Cancer, Victor Velculescu, MD, PhD, about the work of the Dream Team and other efforts in this field of cancer research.

Read More

The Cost of Cancer Disparities

The AACR’s disparities conference covered a wide array of issues this year, from the biological factors that make some racial and ethnic groups especially prone to certain types of cancer, to intriguing new ways to improve prevention and detection, to the cost of cancer disparities.

Read More

Q&A With Raymond DuBois, MD, PhD, on Colorectal Cancer Prevention and Treatment

Raymond DuBois, MD, PhD, past-president of the AACR (2008-2009), fellow of the AACR Academy, and chairman and president of the AACR Foundation, discusses current colorectal cancer screening guidelines, treatment options, and disparities.

Read More

New Combination Chemotherapy for Colorectal Cancer

Last week, the U.S. Food and Drug Administration (FDA) approved a new combination of drugs, formulated together in a single pill called Lonsurf (previously known as TAS-102), to treat patients with advanced colorectal cancer that is no longer responding to other treatments after the treatment was shown in a double-blind, placebo-controlled, phase III clinical trial to extend overall survival.

Read More